STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
46 hedge funds and large institutions have $39.1M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
-6
Holders Change %
-11.54%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
10
Reduced
15
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$1M |
| 2 |
Morgan Stanley
New York
|
+$940K |
| 3 |
Two Sigma Advisers
New York
|
+$844K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$543K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$442K |
